Table 2.

Statistical data of control group and experimental group.

	Control	L-TCA	H-TCA	P value
Baseline body weight (g)	317±15.1	309±24.9	312±13.8	P=0.560
Baseline daily energy intake (kcal)	165±6.3	156±9.3	159±6.0	P=0.665
Baseline fasting blood glucose (mmol/L)	15.9±1.2	15.5±1.0	16.7±1.0	P=0.743
Fasting blood glucose at week 2 (mmol/L)	16.1±0.9	13.6±0.8	13.8±0.7	P=0.067
Fasting blood glucose at week 12 (mmol/L)	17.4±1.1	15.3±0.9	12.9±0.9	P=0.009
Fasting serum insulin at week 2 (ng/ml)	0.51±0.05	0.40±0.07	0.45±0.03	P=0.352
Fasting serum insulin at week 12 (ng/ml)	0.50±0.04	0.47±0.02	0.51±0.07	P=0.807
Matsuda index at week 2	2.8±0.3	3.7±0.5	3.4±0.3	P=0.262
Matsuda index at week 12	2.6±0.2	2.9±0.2	3.8±0.4	P=0.023
Fasting serum GLP-1 at week 2 (pmol/L)	15.4±2.8	13.0±2.2	18.0±3.6	P=0.584
Fasting serum GLP-1 at week 12 (pmol/L)	16.3±3.4	13.5±3.2	17.8±3.6	P=0.666
Fasting serum total bile acids at week 2 (μmol/L)	21.3±1.7	22.4±2.0	24.8±2.2	P=0.462
Fasting serum total bile acids at week 12 (μmol/L)	22.7±2.3	26.6±2.0	28.1±4.1	P=0.246